Pb(II) Induces Scramblase Activation and Ceramide-Domain Generation in Red Blood Cells

Abstract The mechanisms of Pb(II) toxicity have been studied in human red blood cells using confocal microscopy, immunolabeling, fluorescence-activated cell sorting and atomic force microscopy. The process follows a sequence of events, starting with calcium entry, followed by potassium release, morp...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hasna Ahyayauch, Aritz B. García-Arribas, Jesús Sot, Emilio J. González-Ramírez, Jon V. Busto, Bingen G. Monasterio, Noemi Jiménez-Rojo, F. Xabier Contreras, Adela Rendón-Ramírez, Cesar Martin, Alicia Alonso, Félix M. Goñi
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/37d7248c8b5a44c8b4b2d7778320e8bc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:37d7248c8b5a44c8b4b2d7778320e8bc
record_format dspace
spelling oai:doaj.org-article:37d7248c8b5a44c8b4b2d7778320e8bc2021-12-02T15:08:10ZPb(II) Induces Scramblase Activation and Ceramide-Domain Generation in Red Blood Cells10.1038/s41598-018-25905-82045-2322https://doaj.org/article/37d7248c8b5a44c8b4b2d7778320e8bc2018-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-25905-8https://doaj.org/toc/2045-2322Abstract The mechanisms of Pb(II) toxicity have been studied in human red blood cells using confocal microscopy, immunolabeling, fluorescence-activated cell sorting and atomic force microscopy. The process follows a sequence of events, starting with calcium entry, followed by potassium release, morphological change, generation of ceramide, lipid flip-flop and finally cell lysis. Clotrimazole blocks potassium channels and the whole process is inhibited. Immunolabeling reveals the generation of ceramide-enriched domains linked to a cell morphological change, while the use of a neutral sphingomyelinase inhibitor greatly delays the process after the morphological change, and lipid flip-flop is significantly reduced. These facts point to three major checkpoints in the process: first the upstream exchange of calcium and potassium, then ceramide domain formation, and finally the downstream scramblase activation necessary for cell lysis. In addition, partial non-cytotoxic cholesterol depletion of red blood cells accelerates the process as the morphological change occurs faster. Cholesterol could have a role in modulating the properties of the ceramide-enriched domains. This work is relevant in the context of cell death, heavy metal toxicity and sphingolipid signaling.Hasna AhyayauchAritz B. García-ArribasJesús SotEmilio J. González-RamírezJon V. BustoBingen G. MonasterioNoemi Jiménez-RojoF. Xabier ContrerasAdela Rendón-RamírezCesar MartinAlicia AlonsoFélix M. GoñiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-17 (2018)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Hasna Ahyayauch
Aritz B. García-Arribas
Jesús Sot
Emilio J. González-Ramírez
Jon V. Busto
Bingen G. Monasterio
Noemi Jiménez-Rojo
F. Xabier Contreras
Adela Rendón-Ramírez
Cesar Martin
Alicia Alonso
Félix M. Goñi
Pb(II) Induces Scramblase Activation and Ceramide-Domain Generation in Red Blood Cells
description Abstract The mechanisms of Pb(II) toxicity have been studied in human red blood cells using confocal microscopy, immunolabeling, fluorescence-activated cell sorting and atomic force microscopy. The process follows a sequence of events, starting with calcium entry, followed by potassium release, morphological change, generation of ceramide, lipid flip-flop and finally cell lysis. Clotrimazole blocks potassium channels and the whole process is inhibited. Immunolabeling reveals the generation of ceramide-enriched domains linked to a cell morphological change, while the use of a neutral sphingomyelinase inhibitor greatly delays the process after the morphological change, and lipid flip-flop is significantly reduced. These facts point to three major checkpoints in the process: first the upstream exchange of calcium and potassium, then ceramide domain formation, and finally the downstream scramblase activation necessary for cell lysis. In addition, partial non-cytotoxic cholesterol depletion of red blood cells accelerates the process as the morphological change occurs faster. Cholesterol could have a role in modulating the properties of the ceramide-enriched domains. This work is relevant in the context of cell death, heavy metal toxicity and sphingolipid signaling.
format article
author Hasna Ahyayauch
Aritz B. García-Arribas
Jesús Sot
Emilio J. González-Ramírez
Jon V. Busto
Bingen G. Monasterio
Noemi Jiménez-Rojo
F. Xabier Contreras
Adela Rendón-Ramírez
Cesar Martin
Alicia Alonso
Félix M. Goñi
author_facet Hasna Ahyayauch
Aritz B. García-Arribas
Jesús Sot
Emilio J. González-Ramírez
Jon V. Busto
Bingen G. Monasterio
Noemi Jiménez-Rojo
F. Xabier Contreras
Adela Rendón-Ramírez
Cesar Martin
Alicia Alonso
Félix M. Goñi
author_sort Hasna Ahyayauch
title Pb(II) Induces Scramblase Activation and Ceramide-Domain Generation in Red Blood Cells
title_short Pb(II) Induces Scramblase Activation and Ceramide-Domain Generation in Red Blood Cells
title_full Pb(II) Induces Scramblase Activation and Ceramide-Domain Generation in Red Blood Cells
title_fullStr Pb(II) Induces Scramblase Activation and Ceramide-Domain Generation in Red Blood Cells
title_full_unstemmed Pb(II) Induces Scramblase Activation and Ceramide-Domain Generation in Red Blood Cells
title_sort pb(ii) induces scramblase activation and ceramide-domain generation in red blood cells
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/37d7248c8b5a44c8b4b2d7778320e8bc
work_keys_str_mv AT hasnaahyayauch pbiiinducesscramblaseactivationandceramidedomaingenerationinredbloodcells
AT aritzbgarciaarribas pbiiinducesscramblaseactivationandceramidedomaingenerationinredbloodcells
AT jesussot pbiiinducesscramblaseactivationandceramidedomaingenerationinredbloodcells
AT emiliojgonzalezramirez pbiiinducesscramblaseactivationandceramidedomaingenerationinredbloodcells
AT jonvbusto pbiiinducesscramblaseactivationandceramidedomaingenerationinredbloodcells
AT bingengmonasterio pbiiinducesscramblaseactivationandceramidedomaingenerationinredbloodcells
AT noemijimenezrojo pbiiinducesscramblaseactivationandceramidedomaingenerationinredbloodcells
AT fxabiercontreras pbiiinducesscramblaseactivationandceramidedomaingenerationinredbloodcells
AT adelarendonramirez pbiiinducesscramblaseactivationandceramidedomaingenerationinredbloodcells
AT cesarmartin pbiiinducesscramblaseactivationandceramidedomaingenerationinredbloodcells
AT aliciaalonso pbiiinducesscramblaseactivationandceramidedomaingenerationinredbloodcells
AT felixmgoni pbiiinducesscramblaseactivationandceramidedomaingenerationinredbloodcells
_version_ 1718388244314324992